PUBLISHER: KBV Research | PRODUCT CODE: 1457297
PUBLISHER: KBV Research | PRODUCT CODE: 1457297
North America Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Country and Growth Forecast, 2023 - 2030
The North America Theranostics Market would witness market growth of 14.6% CAGR during the forecast period (2023-2030).
The US market dominated the North America Theranostics Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,621.7 million by 2030. The Canada market is experiencing a CAGR of 17.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 16.1% during (2023 - 2030).
Theranostic, a portmanteau of "therapeutics" and "diagnostics," represents a convergence of diagnostic imaging, molecular diagnostics, and targeted therapies, enabling personalized and precision medicine approaches tailored to individual patient characteristics. Diagnostic imaging modalities such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and magnetic resonance imaging (MRI) provide detailed anatomical and functional information, allowing for the visualization and characterization of disease processes.
Theranostic approaches are used for cancer diagnosis, staging, treatment selection, and monitoring. Diagnostic imaging modalities such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and magnetic resonance imaging (MRI) coupled with molecular imaging agents enable accurate localization and characterization of tumours. Molecular diagnostics, including next-generation sequencing (NGS) and polymerase chain reaction (PCR), identify genetic mutations, biomarkers, and molecular signatures associated with specific cancer types, guiding treatment decisions.
The prevalence of cancer in Canada underscores the importance of precision medicine approaches in cancer care. These allow personalized treatment strategies tailored to individual patients based on their tumor characteristics, genetic makeup, and treatment responses. According to the Canadian Cancer Society, researchers estimated that there were 239,100 new cancer cases and 86,700 cancer deaths in Canada in 2023. Hence, the high cancer incidence is propelling the region's market growth.
Based on End User, the market is segmented into Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers. Based on Product, the market is segmented into Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services. Based on Application, the market is segmented into Prostate Cancer, Bone Metastasis, Other Cancers, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Bayer AG
- GE HealthCare Technologies, Inc.
- Siemens Healthineers AG (Siemens AG)
- Cardinal Health, Inc.
- Canon, Inc.
- Clarity Pharmaceuticals Ltd
- Koninklijke Philips N.V.
- Thermo Fisher Scientific, Inc.
- Telix Pharmaceuticals Limited
- ABX advanced biochemical compounds GmbH
North America Theranostics Market Report Segmentation
By End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
By Product
- Radiopharmaceuticals
- Diagnostic Imaging
- IVD/Biomarker Screening
- Software & Services
By Application
- Prostate Cancer
- Bone Metastasis
- Other Cancers
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1North America Theranostics Market, by End User
- 1.4.2North America Theranostics Market, by Product
- 1.4.3North America Theranostics Market, by Application
- 1.4.4North America Theranostics Market, by Country
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
- 3.3Porter's Five Forces Analysis
Chapter 4.North America Theranostics Market by End User
- 4.1North America Hospitals & Cancer Care Centers Market by Country
- 4.2North America Theranostics Centers Market by Country
- 4.3North America Research & Academic Centers Market by Country
Chapter 5.North America Theranostics Market by Product
- 5.1North America Radiopharmaceuticals Market by Country
- 5.2North America Diagnostic Imaging Market by Country
- 5.3North America IVD/Biomarker Screening Market by Country
- 5.4North America Software & Services Market by Country
Chapter 6.North America Theranostics Market by Application
- 6.1North America Prostate Cancer Market by Country
- 6.2North America Bone Metastasis Market by Country
- 6.3North America Other Cancers Market by Country
- 6.4North America Others Market by Country
Chapter 7.North America Theranostics Market by Country
- 7.1US Theranostics Market
- 7.1.1US Theranostics Market by End User
- 7.1.2US Theranostics Market by Product
- 7.1.3US Theranostics Market by Application
- 7.2Canada Theranostics Market
- 7.2.1Canada Theranostics Market by End User
- 7.2.2Canada Theranostics Market by Product
- 7.2.3Canada Theranostics Market by Application
- 7.3Mexico Theranostics Market
- 7.3.1Mexico Theranostics Market by End User
- 7.3.2Mexico Theranostics Market by Product
- 7.3.3Mexico Theranostics Market by Application
- 7.4Rest of North America Theranostics Market
- 7.4.1Rest of North America Theranostics Market by End User
- 7.4.2Rest of North America Theranostics Market by Product
- 7.4.3Rest of North America Theranostics Market by Application
Chapter 8.Company Profiles
- 8.1Bayer AG
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5Recent strategies and developments:
- 8.1.5.1Acquisition and Mergers:
- 8.1.6SWOT Analysis
- 8.2GE HealthCare Technologies, Inc.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expenses
- 8.2.5Recent strategies and developments:
- 8.2.5.1Partnerships, Collaborations, and Agreements:
- 8.2.6SWOT Analysis
- 8.3Siemens Healthineers AG (Siemens AG)
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Segmental and Regional Analysis
- 8.3.4Research & Development Expense
- 8.3.5Recent strategies and developments:
- 8.3.5.1Product Launches and Product Expansions:
- 8.3.6SWOT Analysis
- 8.4Cardinal Health, Inc.
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Segmental and Regional Analysis
- 8.4.4SWOT Analysis
- 8.5Canon, Inc.
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expenses
- 8.5.5SWOT Analysis
- 8.6Clarity Pharmaceuticals Ltd
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Research & Development Expenses
- 8.6.4SWOT Analysis
- 8.7Koninklijke Philips N.V.
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expense
- 8.7.5SWOT Analysis
- 8.8Thermo Fisher Scientific, Inc.
- 8.8.1Company Overview
- 8.8.2Financial Analysis
- 8.8.3Segmental and Regional Analysis
- 8.8.4Research & Development Expenses
- 8.8.5SWOT Analysis
- 8.9Telix Pharmaceuticals Limited
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expenses
- 8.9.5SWOT Analysis
- 8.10.ABX advanced biochemical compounds GmbH
- 8.10.1Company Overview
- 8.10.2SWOT Analysis
LIST OF TABLES
- TABLE 1North America Theranostics Market, 2019 - 2022, USD Million
- TABLE 2North America Theranostics Market, 2023 - 2030, USD Million
- TABLE 3North America Theranostics Market by End User, 2019 - 2022, USD Million
- TABLE 4North America Theranostics Market by End User, 2023 - 2030, USD Million
- TABLE 5North America Hospitals & Cancer Care Centers Market by Country, 2019 - 2022, USD Million
- TABLE 6North America Hospitals & Cancer Care Centers Market by Country, 2023 - 2030, USD Million
- TABLE 7North America Theranostics Centers Market by Country, 2019 - 2022, USD Million
- TABLE 8North America Theranostics Centers Market by Country, 2023 - 2030, USD Million
- TABLE 9North America Research & Academic Centers Market by Country, 2019 - 2022, USD Million
- TABLE 10North America Research & Academic Centers Market by Country, 2023 - 2030, USD Million
- TABLE 11North America Theranostics Market by Product, 2019 - 2022, USD Million
- TABLE 12North America Theranostics Market by Product, 2023 - 2030, USD Million
- TABLE 13North America Radiopharmaceuticals Market by Country, 2019 - 2022, USD Million
- TABLE 14North America Radiopharmaceuticals Market by Country, 2023 - 2030, USD Million
- TABLE 15North America Diagnostic Imaging Market by Country, 2019 - 2022, USD Million
- TABLE 16North America Diagnostic Imaging Market by Country, 2023 - 2030, USD Million
- TABLE 17North America IVD/Biomarker Screening Market by Country, 2019 - 2022, USD Million
- TABLE 18North America IVD/Biomarker Screening Market by Country, 2023 - 2030, USD Million
- TABLE 19North America Software & Services Market by Country, 2019 - 2022, USD Million
- TABLE 20North America Software & Services Market by Country, 2023 - 2030, USD Million
- TABLE 21North America Theranostics Market by Application, 2019 - 2022, USD Million
- TABLE 22North America Theranostics Market by Application, 2023 - 2030, USD Million
- TABLE 23North America Prostate Cancer Market by Country, 2019 - 2022, USD Million
- TABLE 24North America Prostate Cancer Market by Country, 2023 - 2030, USD Million
- TABLE 25North America Bone Metastasis Market by Country, 2019 - 2022, USD Million
- TABLE 26North America Bone Metastasis Market by Country, 2023 - 2030, USD Million
- TABLE 27North America Other Cancers Market by Country, 2019 - 2022, USD Million
- TABLE 28North America Other Cancers Market by Country, 2023 - 2030, USD Million
- TABLE 29North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 30North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 31North America Theranostics Market by Country, 2019 - 2022, USD Million
- TABLE 32North America Theranostics Market by Country, 2023 - 2030, USD Million
- TABLE 33US Theranostics Market, 2019 - 2022, USD Million
- TABLE 34US Theranostics Market, 2023 - 2030, USD Million
- TABLE 35US Theranostics Market by End User, 2019 - 2022, USD Million
- TABLE 36US Theranostics Market by End User, 2023 - 2030, USD Million
- TABLE 37US Theranostics Market by Product, 2019 - 2022, USD Million
- TABLE 38US Theranostics Market by Product, 2023 - 2030, USD Million
- TABLE 39US Theranostics Market by Application, 2019 - 2022, USD Million
- TABLE 40US Theranostics Market by Application, 2023 - 2030, USD Million
- TABLE 41Canada Theranostics Market, 2019 - 2022, USD Million
- TABLE 42Canada Theranostics Market, 2023 - 2030, USD Million
- TABLE 43Canada Theranostics Market by End User, 2019 - 2022, USD Million
- TABLE 44Canada Theranostics Market by End User, 2023 - 2030, USD Million
- TABLE 45Canada Theranostics Market by Product, 2019 - 2022, USD Million
- TABLE 46Canada Theranostics Market by Product, 2023 - 2030, USD Million
- TABLE 47Canada Theranostics Market by Application, 2019 - 2022, USD Million
- TABLE 48Canada Theranostics Market by Application, 2023 - 2030, USD Million
- TABLE 49Mexico Theranostics Market, 2019 - 2022, USD Million
- TABLE 50Mexico Theranostics Market, 2023 - 2030, USD Million
- TABLE 51Mexico Theranostics Market by End User, 2019 - 2022, USD Million
- TABLE 52Mexico Theranostics Market by End User, 2023 - 2030, USD Million
- TABLE 53Mexico Theranostics Market by Product, 2019 - 2022, USD Million
- TABLE 54Mexico Theranostics Market by Product, 2023 - 2030, USD Million
- TABLE 55Mexico Theranostics Market by Application, 2019 - 2022, USD Million
- TABLE 56Mexico Theranostics Market by Application, 2023 - 2030, USD Million
- TABLE 57Rest of North America Theranostics Market, 2019 - 2022, USD Million
- TABLE 58Rest of North America Theranostics Market, 2023 - 2030, USD Million
- TABLE 59Rest of North America Theranostics Market by End User, 2019 - 2022, USD Million
- TABLE 60Rest of North America Theranostics Market by End User, 2023 - 2030, USD Million
- TABLE 61Rest of North America Theranostics Market by Product, 2019 - 2022, USD Million
- TABLE 62Rest of North America Theranostics Market by Product, 2023 - 2030, USD Million
- TABLE 63Rest of North America Theranostics Market by Application, 2019 - 2022, USD Million
- TABLE 64Rest of North America Theranostics Market by Application, 2023 - 2030, USD Million
- TABLE 65Key Information - Bayer AG
- TABLE 66Key Information - GE HealthCare Technologies, Inc.
- TABLE 67Key Information - Siemens Healthineers AG
- TABLE 68key information - Cardinal Health, Inc.
- TABLE 69Key Information - Canon, Inc.
- TABLE 70Key Information - Clarity Pharmaceuticals Ltd
- TABLE 71Key Information - Koninklijke Philips N.V.
- TABLE 72Key Information - Thermo Fisher Scientific, Inc.
- TABLE 73Key Information - Telix Pharmaceuticals Limited
- TABLE 74Key Information - ABX advanced biochemical compounds GmbH
